DFDA

Diuretics (e.g., Furosemide) for Symptom Management

Treatment for Non Rheumatic Degenerative Mitral Valve Disease

Typical Dosage: Furosemide 20-80mg daily/BID

Effectiveness
60%
Safety Score
70%
Clinical Trials
800
Participants
150K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Furosemide 20-80mg daily/BID
Time to Effect
Hours
Treatment Duration
Lifetime
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$500
Side Effect Mgmt:$100
Total Annual:$700
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$10,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$823.53
Diuretics (e.g., Furosemide) for Symptom Management Outcomes

for Non Rheumatic Degenerative Mitral Valve Disease

Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+85%
Common Side Effects
Electrolyte imbalance (e.g., hypokalemia)
+20%
Dehydration/Hypotension
+10%
Renal dysfunction
+7%
Ototoxicity (with high doses)
+0.5%

Sources:

nih.gov
researchgate.net
semanticscholar.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov